D.SAP, an apple-based formulation could treat SARS-CoV-2 infection, and reduce associated inflammatory responses in COVID-19 infected mice model

Author:

Dezhakam Hossein1,Dezhakam Amin1,Dezhakam Ani1,Haghighatfard Arvin1

Affiliation:

1. Khwarizmi Institute of science and technology, Qeshm island, Hormozgan, Iran

Abstract

Abstract Introduction: The SARS-CoV-2 virus is a virus that may cause severe respiratory disorders with an unclear rate of death. Natural vinegar may have an immune-boosting quality that effectively fights influenza-like respiratory infections. We aimed to evaluate the role of a specially formulated Iranian apple vinegar called Dezhakam sap (D.SAP) in the mice model of covid-19 in the treatment of infection and reduction of covid19-associated lung inflammation. Methods: We designed a covid-19-positive model of male inbred BALB/c mice by viral exposure. Then all mice were examined for active SARS-CoV-2 infection. Mice with positive covid-19 infection were separated into different groups to study the effect of treatment by different concentrations of D.SAP smoke for seven days. Expression assessments for viral RNA on covid-19 affected mice models for three SARS-CoV-2 genes (RDRP, N, and E) and three inflammation markers (IL6, IL1b, and TNF) in lung tissue of all mice were assessed using Real-time PCR. Results: Results showed a significant decrease in viral load in the RDRP gene, N gene, and E gene in all infected rats treated with D.SAP compared with off-treatment mice. In addition, all three inflammation factor genes in infected mice that were treated with D.SAP were significantly reduced compared to the off-treatment infected mice. Conclusion: Findings showed the effectiveness of specially formulated apple vinegar D.SAP to attack new coronavirus. In addition, results may suggest the effectiveness of D.SAP to reduce the lethal inflammation in COVID-19 infection with low side effects. Anti-inflammatory agents block certain substances in the body that cause inflammation. D.SAP may consider a potential natural anti-inflammatory that may increase the survival rate of COVID-19 infection. It seems these effects could be related to the antimicrobial and antioxidant effects of D.SAP due to its polyphenolic compounds.

Publisher

Research Square Platform LLC

Reference23 articles.

1. Intuitive vision and indigenous immunity boosting approaches for COVID19: From the literature of Pandit Shriram Sharma Acharya;Satuna RK;Dev Sanskriti Interdisciplinary International Journal. 2020 Jul

2. Vianello A, Guarnieri G, Braccioni F, Lococo S, Molena B, Cecchetto A, Giraudo C, De Marchi LB, Caminati M, Senna G. The pathogenesis, epidemiology and biomarkers of susceptibility of pulmonary fibrosis in COVID-19 survivors. Clinical Chemistry and Laboratory Medicine (CCLM). 2022 Feb 1;60(3):307 – 16.

3. Blood targets of adjuvant drugs against COVID19;Micco P;Journal of Blood Medicine,2020

4. ACE2, COVID19 and serum ACE as a possible biomarker to predict severity of disease;Kolberg ES;Journal of Clinical Virology,2020

5. Sarowska J, Wojnicz D, Jama-Kmiecik A, Frej-Mądrzak M, Choroszy-Król I. Antiviral potential of plants against noroviruses. Molecules. 2021 Aug 2;26(15):4669.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3